What were the key takeaways from Enpro’s earnings call?

What is Enpro's latest dividend and current dividend yield?

What is the revenue and EPS growth rate for Enpro year over year?

What were the key takeaways from Enpro's earnings call?

What factors drove the changes in Enpro's revenue and profit?

What guidance did Enpro's management provide for the next earnings period?

What is Enpro's gross profit margin?

Did Enpro beat or miss consensus estimates last quarter?

- **Revenue Growth**: 2025 organic sales +7.6%, 2026 guidance 8-12%. Sealing Technologies targets 15% growth, AST expects H2 margin expansion.
- **Profitability**: 2025 adjusted EBITDA $305M, 2026 target $305-320M. Sealing Technologies EBITDA margin >30%, AST margin expansion in H2.
- **Strategic Acquisitions**: $280M spent on AlpHa and Overlook, enhancing growth in food/biopharma and compositional analysis.
- **Semiconductor Recovery**: AST poised to benefit from H2 semiconductor capital equipment spending, with 2 new platforms launching late 2026.
- **Financial Strength**: Free cash flow $150M+ in 2025, net leverage 2x, dividend increased to $0.32/share.

**【CEO Summary Section】**
- **Enpro 3.0 Strategy Progress**: Achieved 7.6% organic growth in 2025, with Sealing Technologies and AST segments driving strong performance. Acquired AlpHa and Overlook for $280M, enhancing growth potential.
- **2025 Financial Highlights**: Total sales $1.14B (+9%), adjusted EBITDA $305M, free cash flow $150M. Sealing Technologies EBITDA margin 32.8%, AST EBITDA margin 20%.
- **2026 Outlook**: Sales growth 8-12%, adjusted EBITDA $305-320M, EPS $8.50-9.20. Sealing Technologies targets 15% growth, AST expects high-single-digit growth with margin expansion in H2.
- **Safety Performance**: Record-low TRIR of 0.64, reflecting operational excellence and commitment to safety.

**【CFO Financial Commentary】**
- **Q4 2025 Results**: Sales $295.4M (+14.3%), adjusted EBITDA $69.4M (+19.2%), EPS $1.99 (+27%). Sealing Technologies organic growth 8%, AST sales +13.4%.
- **Balance Sheet**: Net leverage 2x, $580M available on $800M credit facility. Free cash flow expected to grow in 2026, supporting M&A and CapEx.
- **2026 Guidance**: Capital expenditures $50M (4% of sales), dividend increased to $0.32/share. AST to benefit from semiconductor recovery, Sealing Technologies to leverage aftermarket stability.

**【Q&A Key Highlights】**
- **AST Margin Recovery**: Q2 2026 onward, margins to improve as order flow accelerates, with 2 new platforms launching late H2. H2 EBITDA margin expected to be 'materially better' than H1.
- **Sealing Technologies Resilience**: 65% of sales tied to aftermarket, with aerospace and food/biopharma leading growth. Commercial vehicle OEM recovery expected in H2.
- **M&A Pipeline**: $250-300M available for strategic acquisitions, focusing on complementary technologies in food/biopharma and compositional analysis.
- **Cash Flow Conversion**: Free cash flow ~100% of adjusted EPS, with $150M+ expected in 2026. Capital allocation prioritizes growth and returns.


Enpro Inc. (NPO) Q4 2025 Earnings Call Transcript

- **Q3 Growth**: 10% organic sales, driven by 17% AST growth and 5.7% Sealing Technologies expansion. Adjusted EBITDA margin 24.2%.
- **Acquisition Boost**: $60+ million 2026 revenue from Overlook and AlpHa, with $17-18 million EBITDA contribution.
- **Segment Momentum**: Sealing Technologies targeting mid-single-digit growth; AST precision cleaning solutions lead semiconductor node adoption.
- **Financial Strength**: 14.3% EPS growth to $1.99; 2025 guidance updated to 7-8% revenue growth, $275-280 million EBITDA.
- **Future Investments**: Biopharma, aerospace, and semiconductor capacity expansions; 2026 capex to support organic and M&A growth.

**【CEO Summary Section】**
- **Q3 2025 Performance**: Organic sales grew nearly 10%, with Sealing Technologies up 5.7% and Advanced Surface Technologies (AST) up 17.3%. Adjusted EBITDA margin was 24.2%.
- **Acquisitions**: Overlook Industries and AlpHa Measurement Solutions, closing in Q4, are expected to contribute $60+ million in 2026 revenue and $17-18 million in EBITDA. Both fit Enpro's strategic growth criteria.
- **Segment Growth**: Sealing Technologies targets mid-single-digit revenue growth; AST aims for high single to low double-digit growth. AST's precision cleaning solutions are driving advanced semiconductor node adoption.
- **Investments**: Expanding capacity in aerospace, biopharma, and semiconductor sectors to support long-term growth. Overlook enhances biopharma single-use technologies, while AlpHa broadens sensing capabilities.

**【CFO Financial Commentary】**
- **Q3 Financials**: Revenue $286.6 million (+9.8% YoY), adjusted EBITDA $69.3 million (+8%), adjusted EPS $1.99 (+14.3%).
- **Segment Margins**: Sealing Technologies EBITDA margin >32%; AST margin 20.1%, impacted by mix and investments.
- **Updated Guidance**: Full-year 2025 revenue growth 7-8%, EBITDA $275-280 million, EPS $7.75-8.05. Acquisitions contribute ~$10 million Q4 revenue.
- **Balance Sheet**: Net leverage ~1.2x; 2025 free cash flow $105 million. Share buyback authorization remains at $50 million.

**【Q&A Highlights】**
- **Acquisition Impact**: Both businesses expected to grow high single to low double-digit, with margins meeting or exceeding core. Overlook's biopharma expertise and AlpHa's sensing tech complement Enpro's portfolio.
- **AST Dynamics**: $12 million legacy tools sales in 2025 reflect regional demand shifts. 2026 outlook: choppy Q1-Q2, stronger H2 with advanced node qualification.
- **Compositional Analysis**: AMI and AlpHa acquisitions expand into liquid/gas sensing, targeting industrial, environmental, and biopharma markets. Additional M&A opportunities exist in this space.
- **CapEx Outlook**: ~$50 million 2025, supporting growth in semiconductor, biopharma, and aerospace. 2026 capex expected to remain elevated for organic expansion.


Enpro Inc. (NPO) Q3 2025 Earnings Call Transcript

- **Revenue Growth**: 6% organic sales growth (Q2 2025), driven by 14.5% AST expansion and resilient Sealing Technologies (33.8% EBITDA margin).
- **Guidance Uptick**: Full-year 2025 EBITDA raised to $270-280M (vs. $262-277M) on stronger aerospace and food/pharma demand.
- **FX Challenges**: $4.7M total Q2 FX headwinds in Sealing and AST, but expected to stabilize in H2.
- **AST Expansion**: $2.5M OpEx investments in new facilities poised to drive high single-digit growth in H2.
- **Strategic M&A**: Actively pursuing 5-8% revenue growth opportunities in niche markets like compositional analysis.

**【CEO Summary Section】**
- Enpro reported 6% organic sales growth in Q2 2025, driven by 14.5% revenue growth in Advanced Surface Technologies (AST) and 2% growth in Sealing Technologies. 
- Sealing Technologies achieved a 33.8% adjusted EBITDA margin, with strength in aerospace, food/pharma, and general industrial markets offsetting commercial vehicle OEM weakness.
- AST growth was fueled by precision cleaning solutions, optical coatings, and semiconductor tools, despite $2.8M FX headwinds.
- Enpro 3.0 strategy emphasizes personal and profitable growth, with employees pursuing development plans to enhance business acumen and problem-solving skills.

**【CFO Financial Commentary】**
- Q2 2025 revenue: $288.1M (6% YoY growth); adjusted EBITDA: $71.1M (down 3.9% YoY due to higher OpEx, FX, and incentive comp).
- Full-year 2025 guidance raised to 5-7% sales growth, $270-280M adjusted EBITDA, and $7.60-8.10 EPS (vs. prior $262-277M EBITDA and $7-7.70 EPS).
- Balance sheet remains strong with $364M net debt (1.4x net leverage) and $52.8M free cash flow YTD.
- Capital expenditures expected at $50M for 2025, supporting growth initiatives.

**【Q&A Key Highlights】**
- **FX Impact**: Sealing Technologies faced $1.9M FX headwinds; AST incurred $2.8M FX losses due to U.S. dollar weakening.
- **Nuclear Orders**: Timing shifts caused Q2 weakness, but underlying demand remains strong.
- **AST Growth**: Second-half leverage expected as $2.5M OpEx investments in Arizona, Milpitas, and Taiwan start to yield results.
- **M&A Pipeline**: Active in 5-8% revenue growth markets (e.g., compositional analysis, aerospace), with focus on strategic fit and financial rigor.
- **AMI Success**: Compositional analysis business exceeded expectations, with capacity expansion underway.


Enpro Inc. (NPO) Q2 2025 Earnings Call Transcript

- **Revenue Growth**: 6% organic sales rise to $273.2M, driven by aerospace and precision cleaning solutions.
- **Profitability**: 16% EBITDA growth to $67.8M (24.8% margin), with Sealing Technologies maintaining >30% margins.
- **Tariff Resilience**: Minimal impact (<1% revenue exposed), supply chain agility mitigates risks.
- **Market Momentum**: Aerospace/space (+20%), food/pharma recovery, and semiconductor capital equipment choppy but improving.
- **Balance Sheet Strength**: $193M cash, 1.5x net leverage, and $800M credit facility support growth initiatives.

**【CEO Opening Remarks】**
- Q1 2025 organic sales grew 6% to $273.2M, driven by Sealing Technologies (4.5% growth) and Advanced Surface Technologies (9.1% growth). 
- Adjusted EBITDA rose 16% to $67.8M, with margins expanding to 24.8%.
- Sealing Technologies maintained >30% EBITDA margin for the 5th consecutive quarter, supported by aerospace, general industrial, and food/pharma markets.
- AST segment EBITDA margin improved 180bps to 21.9%, despite semiconductor capital equipment weakness.
- Tariff exposure is minimal, with supply chain agility managing risks (e.g., diversifying bearing production to Spain/India).

**【CFO Financial Breakdown】**
- GAAP net income: $42.0M; Non-GAAP EPS: $1.90 (21% YoY growth).
- Free cash flow: $11.6M (seasonally low due to Q1 timing).
- Balance sheet: $580M debt (1.5x net leverage), $193M cash, and $800M revolving credit facility.
- 2025 guidance: Sales growth 3-6%, EBITDA $262-277M, EPS $7-7.70.

**【Q&A Key Takeaways】**
1. **Tariff Impact**: <1% of revenue exposed; 90%+ production is region-for-region. Bearing costs increased ~$1M annually, fully offset by pricing/mix.
2. **Market Outlook**: 
   - Aerospace/space: Double-digit growth
   - Food/pharma: Recovering
   - Commercial vehicle: Flat ton-miles (~0.4% YoY)
3. **M&A Strategy**: Maintaining disciplined approach with $50M share buyback authorization.
4. **Margin Expansion**: 80-20 initiatives drove 5%+ EBITDA margin expansion in Sealing.
5. **AST Arizona Facility**: Phase 1 qualification complete; full production ramp in late 2025.

**【Segment Performance】**
- **Sealing Technologies**: 
  - Aerospace sales +20% YoY
  - Aftermarket accounts for 66% of segment revenue
  - 2025 EBITDA margin target: 30% ±250bps
- **Advanced Surface Technologies**: 
  - Precision cleaning solutions +20% YoY
  - Optical coatings/filters +15% YoY
  - 2025 revenue growth expected 5-8%

EnPro Industries (NPO)-6 May 25-2025 Q1 Earnings call transcript

- **2024 Performance Highlight**: 7% EBITDA growth to $255M, with Sealing Technologies at 32% margin and AST resilience at 21%. 
- **EnPro 3.0 Growth Targets**: Mid-single-digit Sealing, high single-digit AST, both targeting 30%+ margins. 
- **2025 Outlook**: $262-277M EBITDA, $7-7.70 EPS, with AST growth driven by leading-edge solutions despite semiconductor weakness. 
- **Key Risk Mitigation**: Minimal China supply chain exposure, tariff surcharges in place, and safety culture investments driving operational excellence.

**【CEO Summary Section】**
- EnPro achieved 7% year-over-year growth in adjusted EBITDA to $255 million in 2024, driven by strong performance in Sealing Technologies (32% segment EBITDA margin) and resilience in AST (21% segment EBITDA margin). 
- Introduced EnPro 3.0 strategy targeting mid-single-digit growth in Sealing Technologies and high single-digit growth in AST, with both segments aiming for 30%+ EBITDA margins. 
- Highlighted 2024 free cash flow of $130 million and net leverage of 1.6x, supporting strategic investments and dividend growth (+3.2% to $0.31/share). 

**【CFO Financial Commentary】**
- Q4 2024 sales of $258.4 million (+3.7% YoY), with Sealing Technologies up 11% and AST down 6.4%. 
- Adjusted EBITDA of $58.2 million (+24% YoY), driven by Sealing Technologies' 32% margin expansion and strategic pricing. 
- 2025 guidance: low-mid single-digit sales growth, $262-277 million EBITDA, and $7-7.70 EPS. 
- AST expected to grow mid-high single-digits, with margin stabilization above 20% despite semiconductor capex weakness. 

**【Q&A Key Takeaways】**
- **Semiconductor Market**: AST growth will come from leading-edge applications (e.g., advanced chip architectures), with minimal recovery in wafer fab equipment spending. 
- **Tariff Mitigation**: Minimal supply chain exposure to China (3 small facilities), with pricing surcharges to offset tariffs. 
- **CapEx Plan**: 2025 investments ($50M) focused on Arizona facility ramp-up and Sealing Technologies organic growth. 
- **Safety & Culture**: ISO 45001 certifications achieved at 3 locations, with safety metrics exceeding industry benchmarks.

Actual											0.62	0.54	0.67	1.24	1.37	1.56	1.4	1.23	1.83	2.32	1.91	1.47	1.95	1.83	1.58	1.19	1.57	2.08	1.74	1.57	1.9	2.03	1.99	1.99
Forecast											0.4	0.08	0.315	0.505	0.9433	1.24	1.26	1.1267	1.5267	1.75	1.3733	1.2467	1.4867	1.7433	1.5833	1.4367	1.54	1.8467	1.8733	1.4733	1.6667	2.0725	1.9567	1.9133
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+55.00%	+575.00%	+112.70%	+145.54%	+45.23%	+25.81%	+11.11%	+9.17%	+19.87%	+32.57%	+39.08%	+17.91%	+31.16%	+4.97%	-0.21%	-17.17%	+1.95%	+12.63%	-7.12%	+6.56%	+14.00%	-2.05%	+1.70%	+4.01%

NPO

NPO fundamentals

NPO Q4 2025 Earnings

Earnings Call

You can ask Aime

NPO

NPO fundamentals

NPO Q4 2025 Earnings

Earnings Call

NPO Earnings Call Summary for Q4/20258:30 AM on Feb 18, 2026

NPO Earnings Call Summary for Q3/20258:30 AM on Nov 4, 2025

NPO Earnings Call Summary for Q2/20258:30 AM on Aug 5, 2025

NPO Earnings Call Summary for Q1/20258:30 AM on May 6, 2025

NPO Earnings Call Summary for Q4/20248:30 AM on Feb 19, 2025

You can ask Aime